|
OMIM |
Link |
Information gain |
01 |
|
CF
|
[NCBI]
|
0.00113996
|
|
|
hyperimmunoglobulin e-recurrent infection syndrome, autosomal recessive
|
[NCBI]
|
0.000898321
|
|
|
splenic hypoplasia
|
[NCBI]
|
0.000805308
|
|
|
PHP
|
[NCBI]
|
0.00074746
|
|
|
folic acid, transport defect involving
|
[NCBI]
|
0.000705355
|
|
|
neutropenia, chronic familial
|
[NCBI]
|
0.000644945
|
|
|
LAD
|
[NCBI]
|
0.000584128
|
|
|
TNF
|
[NCBI]
|
0.000509514
|
|
|
ITGB2
|
[NCBI]
|
0.00037424
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
0.000362511
|
|
|
MBL2
|
[NCBI]
|
0.000235497
|
|
|
MPO
|
[NCBI]
|
0.000171254
|
|
|
TLR4
|
[NCBI]
|
0.000168382
|
|
|
SDS
|
[NCBI]
|
0.000132554
|
|
|
LBP
|
[NCBI]
|
0.000108529
|
|
|
SPINK1
|
[NCBI]
|
0.000104481
|
|
|
SLE
|
[NCBI]
|
0.000100811
|
|
|
cd8 deficiency, familial
|
[NCBI]
|
9.87317e-05
|
|
|
combined inflammatory and immunologic defect
|
[NCBI]
|
9.87317e-05
|
|
|
IRAK4
|
[NCBI]
|
8.40787e-05
|
|
|
CVID
|
[NCBI]
|
8.34578e-05
|
|
|
irak4 deficiency
|
[NCBI]
|
6.78502e-05
|
|
|
CXCR4
|
[NCBI]
|
6.77256e-05
|
|
|
VEGF
|
[NCBI]
|
6.52377e-05
|
|
|
PGLYRP2
|
[NCBI]
|
6.43314e-05
|
|
|
NOX4
|
[NCBI]
|
6.43314e-05
|
|
|
STAB1
|
[NCBI]
|
6.43314e-05
|
|
|
PGLYRP1
|
[NCBI]
|
6.43314e-05
|
|
|
STAB2
|
[NCBI]
|
6.43314e-05
|
|
|
DPH3
|
[NCBI]
|
6.43314e-05
|
|
|
immunodeficiency with defective leukocyte and lymphocyte function and with response to histamine-1 antagonist
|
[NCBI]
|
6.23785e-05
|
|
|
tuftsin deficiency
|
[NCBI]
|
5.83192e-05
|
|
|
TLR2
|
[NCBI]
|
5.29722e-05
|
|
|
PTGER1
|
[NCBI]
|
5.0566e-05
|
|
|
PGLYRP3
|
[NCBI]
|
5.0566e-05
|
|
|
PGLYRP4
|
[NCBI]
|
5.0566e-05
|
|
|
HSPA8
|
[NCBI]
|
5.0566e-05
|
|
|
complement component 8 deficiency, type ii
|
[NCBI]
|
5.0566e-05
|
|
|
TREM1
|
[NCBI]
|
5.0566e-05
|
|
|
G6PC3
|
[NCBI]
|
5.0566e-05
|
|
|
FGL2
|
[NCBI]
|
5.0566e-05
|
|
|
SLC11A1
|
[NCBI]
|
5.03527e-05
|
|
|
PLG
|
[NCBI]
|
5.01239e-05
|
|
|
HP
|
[NCBI]
|
4.92958e-05
|
|
|
HPS2
|
[NCBI]
|
4.81319e-05
|
|
|
elliptocytosis, rhesus-unlinked type
|
[NCBI]
|
4.81319e-05
|
|
|
CGD
|
[NCBI]
|
4.76805e-05
|
|
|
NOD1
|
[NCBI]
|
4.53799e-05
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
4.33375e-05
|
|
|
IL4
|
[NCBI]
|
4.27515e-05
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
4.20217e-05
|
|
|
SGD
|
[NCBI]
|
4.20217e-05
|
|
|
CD1B
|
[NCBI]
|
4.20174e-05
|
|
|
GFI1
|
[NCBI]
|
4.20174e-05
|
|
|
PTGER3
|
[NCBI]
|
4.20174e-05
|
|
|
CPB1
|
[NCBI]
|
3.9521e-05
|
|
|
EGF
|
[NCBI]
|
3.78549e-05
|
|
|
G6PD
|
[NCBI]
|
3.70258e-05
|
|
|
CFD
|
[NCBI]
|
3.4476e-05
|
|
|
PIK3R1
|
[NCBI]
|
3.4476e-05
|
|
|
HSPCA
|
[NCBI]
|
3.4476e-05
|
|
|
SELE
|
[NCBI]
|
3.4476e-05
|
|
|
EL1
|
[NCBI]
|
3.35574e-05
|
|
|
CLEC4M
|
[NCBI]
|
3.32455e-05
|
|
|
CFTR
|
[NCBI]
|
3.26413e-05
|
|
|
CD209
|
[NCBI]
|
3.2154e-05
|
|
|
CRC
|
[NCBI]
|
3.18946e-05
|
|
|
ADA
|
[NCBI]
|
3.17619e-05
|
|
|
CASP1
|
[NCBI]
|
3.11736e-05
|
|
|
TCRG
|
[NCBI]
|
3.0284e-05
|
|
|
PFC
|
[NCBI]
|
3.0284e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
2.97868e-05
|
|
|
CD8A
|
[NCBI]
|
2.947e-05
|
|
|
STAT4
|
[NCBI]
|
2.80247e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
2.77319e-05
|
|
|
PCD
|
[NCBI]
|
2.7411e-05
|
|
|
CFI
|
[NCBI]
|
2.73768e-05
|
|
|
gastric cancer
|
[NCBI]
|
2.63671e-05
|
|
|
EGFR
|
[NCBI]
|
2.59114e-05
|
|
|
IL1B
|
[NCBI]
|
2.51555e-05
|
|
|
PIGR
|
[NCBI]
|
2.37788e-05
|
|
|
HIF1A
|
[NCBI]
|
2.33618e-05
|
|
|
IFNG
|
[NCBI]
|
2.33618e-05
|
|
|
CHS
|
[NCBI]
|
2.30836e-05
|
|
|
IL12B
|
[NCBI]
|
2.29628e-05
|
|
|
GDF5
|
[NCBI]
|
2.22134e-05
|
|
|
HLA-A
|
[NCBI]
|
2.11932e-05
|
|
|
BCL6
|
[NCBI]
|
2.02765e-05
|
|
|
GC
|
[NCBI]
|
1.99905e-05
|
|
|
C3
|
[NCBI]
|
1.97135e-05
|
|
|
sickle cell anemia
|
[NCBI]
|
1.91771e-05
|
|
|
PRL
|
[NCBI]
|
1.778e-05
|
|
|
RNASE3
|
[NCBI]
|
1.75013e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
1.61715e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
1.59103e-05
|
|
|
PI
|
[NCBI]
|
1.57128e-05
|
|
|
B2M
|
[NCBI]
|
1.51476e-05
|
|
|
IBD1
|
[NCBI]
|
1.4998e-05
|
|
|
RNASE2
|
[NCBI]
|
1.43815e-05
|
|
|
IGFALS
|
[NCBI]
|
1.2106e-05
|
|
|
KLK3
|
[NCBI]
|
1.11915e-05
|
|
|
BTK
|
[NCBI]
|
1.05289e-05
|
|
|
TF
|
[NCBI]
|
1.04201e-05
|
|
|
APOE
|
[NCBI]
|
9.23705e-06
|
|
|
IL6
|
[NCBI]
|
8.33848e-06
|
|
|
ADCYAP1
|
[NCBI]
|
7.84235e-06
|
|
|
ADM
|
[NCBI]
|
6.46088e-06
|
|
|
OSM
|
[NCBI]
|
6.18375e-06
|
|
|
temporal arteritis
|
[NCBI]
|
5.46329e-06
|
|
|
CEACAM5
|
[NCBI]
|
4.89498e-06
|
|
|
PYY
|
[NCBI]
|
4.87365e-06
|
|
|
MAG
|
[NCBI]
|
4.63505e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
4.04942e-06
|
|
|
SOD1
|
[NCBI]
|
3.49967e-06
|
|
|
RA
|
[NCBI]
|
2.48121e-06
|
|
|
IL2
|
[NCBI]
|
2.43084e-06
|
|
|
CAT
|
[NCBI]
|
2.04386e-06
|
|
|
GNRH1
|
[NCBI]
|
1.67284e-06
|
|
|
FMF
|
[NCBI]
|
1.66902e-06
|
|
|
CCK
|
[NCBI]
|
1.64879e-06
|
|
|
ALB
|
[NCBI]
|
1.24741e-06
|
|
|
F3
|
[NCBI]
|
1.21546e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.11576e-06
|
|
|
TNFSF6
|
[NCBI]
|
1.09097e-06
|
|
|
AVP
|
[NCBI]
|
1.03467e-06
|
|
|
TFPI
|
[NCBI]
|
9.69276e-07
|
|
|
WAS
|
[NCBI]
|
9.63407e-07
|
|
|
XDH
|
[NCBI]
|
8.9585e-07
|
|
|
VIP
|
[NCBI]
|
8.57471e-07
|
|
|
MBP
|
[NCBI]
|
4.45727e-07
|
|
|
EPO
|
[NCBI]
|
3.84861e-07
|
|
|
TYMS
|
[NCBI]
|
3.12775e-07
|
|
|
HGF
|
[NCBI]
|
3.02707e-07
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.8865e-07
|
|
|
CRH
|
[NCBI]
|
1.36048e-07
|
|
|
LPL
|
[NCBI]
|
5.48918e-08
|
|
|
HBB
|
[NCBI]
|
1.52955e-08
|
|
|
ALD
|
[NCBI]
|
9.14135e-09
|
|